U.S. Food & Drug Administration grants Priority Review for voclosporin and sets PDUFA date of January 22, 2021 Cash, cash equivalents and short term investments totalled approximately $442.06 million at… Read More
Vancouver, BC — Microbiome Insights Inc., a leading global provider of end-to-end services for microbiome DNA sequencing, including state-of-the-art bioinformatic analysis, has recently published the “How to Plan and Conduct… Read More
Phase 1a/1b clinical trial for AB-729, a subcutaneously delivered RNAi agent, remains on track with results from additional cohorts expected in the second half of 2020 AB-836, an oral capsid… Read More
As LY-CoV555 advances into Phase 3 COVID-19 prevention studies, AbCellera’s COVID-19 database reaches over 2,000 new antibodies against the virus, discovered from recovered patient samples August 3, 2020 VANCOUVER, British… Read More
July 29, 2020 AbCellera is celebrating a double win: the company has been named on Fast Company’s prestigious annual list of Best Workplaces for Innovators. Additionally, AbCellera has been awarded… Read More
